Stocks and Investing Stocks and Investing
Fri, December 10, 2021
[ 12:00 AM ] - WOPRAI
Shagun Singh Initiated (ZBH) at Hold and Held Target at $140 on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
Nick Setyan Downgraded (BJRI) to Hold and Decreased Target to $38 on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
Arvind Ramnani Maintained (BLND) at Buy with Decreased Target to $13 on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
Shagun Singh Initiated (BSX) at Buy and Held Target at $51 on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
Haendel St. Juste Maintained (BRX) at Hold with Increased Target to $26 on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
Tyler Langton Downgraded (BTG) to Sell on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
Kate Fitzsimons Maintained (ASO) at Buy with Increased Target to $62 on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
Douglas Becker Initiated (ASPN) at Strong Buy and Held Target at $70 on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
John Kim Upgraded (AVB) to Buy and Held Target at $285 on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
Justin Kim Upgraded (AUPH) to Buy and Decreased Target to $31 on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
Michael Sison Maintained (AVNT) at Buy with Increased Target to $65 on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
John Vinh Maintained (AVGO) at Buy with Increased Target to $71 on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
Hans Mosesmann Maintained (AVGO) at Strong Buy with Increased Target to $75 on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
John Pitzer Maintained (AVGO) at Buy with Increased Target to $70 on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
Aaron Rakers Maintained (AVGO) at Hold with Increased Target to $64 on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
Craig Hettenbach Maintained (AVGO) at Buy with Increased Target to $72 on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
Harsh Kumar Maintained (AVGO) at Buy with Increased Target to $68 on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
Ambrish Srivastava Maintained (AVGO) at Buy with Increased Target to $68 on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
Vijay Rakesh Maintained (AVGO) at Strong Buy with Increased Target to $67 on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
Nicole Deblase Downgraded (CARR) to Hold and Decreased Target to $56 on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
Sean Horgan Maintained (CBOE) at Strong Buy with Increased Target to $151 on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
Susan Roth Katzke Maintained (C) at Buy with Decreased Target to $76 on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
Daniel Fannon Maintained (TROW) at Strong Buy and Held Target at $245 on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
Kartik Mehta Initiated (TOST) at Hold on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
Shagun Singh Initiated (SYK) at Hold and Held Target at $278 on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
Julio Romero Upgraded (TGLS) to Strong Buy on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
Erika Najarian Initiated (TFC) at Hold and Held Target at $63 on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
Shagun Singh Initiated (TFX) at Buy and Held Target at $415 on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
Joseph Spak Maintained (TEL) at Buy and Held Target at $166 on, Dec 10th, 2021
[ 12:00 AM ] - WOPRAI
Aydin Huseynov Initiated (SPRB) at Buy and Held Target at $7 on, Dec 10th, 2021

Aydin Huseynov Initiated (SPRB) at Buy and Held Target at $7 on, Dec 10th, 2021


Published on 2024-10-27 18:56:21 - WOPRAI, Aydin Huseynov
  Print publication without navigation


Aydin Huseynov of Benchmark, Initiated "Spruce Biosciences, Inc." (SPRB) at Buy and Held Target at $7 on, Dec 10th, 2021.

Aydin has made no other calls on SPRB in the last 4 months.



There are 4 other peers that have a rating on SPRB. Out of the 4 peers that are also analyzing SPRB, 2 agree with Aydin's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Ritu Baral of "Cowen & Co." Downgraded from Buy to Hold on, Tuesday, November 23rd, 2021
  • Joseph Schwartz of "SVB Leerink" Downgraded from Buy to Hold and Decreased Target to $5 on, Tuesday, November 16th, 2021


These are the ratings of the 2 analyists that currently disagree with Aydin

  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Decreased Target to $6 on, Tuesday, November 16th, 2021
  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $20 on, Tuesday, November 16th, 2021
Contributing Sources